Mike Hsu aims to stoke the consumer company’s growth by veering into Kenvue’s higher-margin but risky health products.

One of biggest takeovers so far this year will create a global company with annual revenues of roughly $32 billion.

Kleenex and Cottonelle maker Kimberly-Clark said it's buying Tylenol maker Kenvue in a $48.7 billion deal. Kenvue ( KVUE) ...

Kimberly-Clark is buying Tylenol maker Kenvue in an approximately $48.7 billion cash-and-stock deal, creating a massive ...

Kimberly-Clark is laying down $40 billion to buy Kenvue in a massive deal that has puzzled some investors as the Tylenol ...

The consumer products giant reached a $40 billion deal to buy Kenvue, the maker of Tylenol, despite a barrage of unproven ...

One of the biggest mergers of the year, worth $49 billion, comes just weeks after the Trump administration linked the common ...

The owner of Kleenex and Huggies will acquire the embattled company, which has fought claims by the Trump administration that a common pain reliever is linked to harmful side effects.

Kimberly-Clark agreed to buy Kenvue in a cash-and-stock transaction that values the Tylenol maker at an enterprise value of ...

Kimberly-Clark Corp. will acquire Tylenol maker Kenvue Inc. in a cash and stock deal valued at almost $49 billion the two ...

President Donald Trump has claimed Kenvue’s pain reliever is a potential cause of autism, despite clear evidence.

Kimberly-Clark is making a big move with a nearly $50 billion acquisition. The North Texas company plans to acquire Kenvue ...